Provides that a pharmacist may not interchange an antiepileptic drug or formulation of an antiepileptic drug, brand name or generic, for the treatment of seizures without prior notification of and the consent for such interchange from the prescribing physician and patient, or patient's parent, legal guardian, or spouse.